QSI earnings

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the first quarter 2026 on Thursday, May 7, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individua

Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, 2025. Press Release Highlights Reported fourth quarter revenue of $451,000 Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities Announced list price for Proteus of $425,000 Announced 2026 Financial Guidance

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternat

Announces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the third quarter ended September 30, 2025. Press Release Highlights Reported revenue of $552,000 for the third quarter of 2025 Announced successful sequencing runs on a prototype Proteus system. The development program remains on track. Highlighted early success with instrument placement program, providing increased access to academic customers Highlighted recent launch and

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the third quarter 2025 on Wednesday, November 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, ind

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2025 on Tuesday, August 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, indivi

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2025 on Thursday, May 15, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personali

Achieves First Quarterly Revenue Over $1 Million Completes Capital Raises of $86 Million Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the fourth quarter and full year ended December 31, 2024. Press Release Highlights Reported revenue of $1.2 million for the fourth quarter of 2024 and $3.1 million for the full year 2024 (representing a 183% full year-over-year growth) Raised capital of over $86 million between the fourth quarter of 2024 and first week of 2025 (extending cash runway into the second half of 2027) Announced the launch of Platinum® Pro in January 2025, with shipp

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in numbe

Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum® Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appointments of industry veteran Todd Bennett as Chief Commercial Officer ("CCO"), John Vieceli, Ph.D. as Chief Product Officer and Lindsay Thompson as C

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter of 2024 on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:00 AM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event

Announces Release of Version 3 Sequencing Kit Announces Two Additional Kit Launches Expected by End of 2024 Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2024.   Press Release Highlights   Reported revenue of $622,000 in the second quarter of 2024 Completed the first quarter of full commercial launch of the Platinum® instrument in Q2 2024 Announces the launch of the version 3 sequencing kit Announced appointment of Chuck Kummeth as independent Chairman of the Board of Directors Expect to l

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter of 2024 on Wednesday, August 7, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the eve

Executed Full Commercial Launch of Platinum® Instrument Reaffirms Full Year 2024 Financial Guidance Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue of $457,000 in the first quarter of 2024 Commenced its full commercial launch of its Platinum® instrument at the end of March 2024 On track to launch version 3 of its sequencing kit, which is expected by the end of Q3 2024 Announced addition of Paula Dowdy to the Board of Directors Announced the release of a new version of Platinum® Analysis Soft

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will b

Finalizing Commercial Readiness for Expected Full Commercial Launch by the End of Q1 2024 Releases Full Year 2024 Financial Guidance Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced financial results for the fourth quarter and full year ended December 31, 2023. Press Release Highlights Recorded revenue of $400,000 in the fourth quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum® instrument Finalizing commercial readiness for expected full commercial launch by the end of Q1 2024 Launched version 2 of its sequencing kit in early February 2

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcas

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum instrument Completed a strategic review of research and development ("R&D") programs and organizational design; resulting changes will focus development on rapid delivery of capabilities and applications with the highest customer demand First customer data presented in an October webinar titled "Next-generation p

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event wi

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum™ instruments. Strengthened the Board of Directors with the addition of Scott Mendel and Jack Kenny. Since May 2023, strengthened the Executive Management team with the additions of Jeff Keyes as Chief Financial Officer and Johan Denecke as Senior Vice President, Operations Published five new applications notes since May 2023 demonstrating the use of

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter 2023 on Monday, August 7, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will

Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8% This was the Company's first quarter of revenue generated on the sale of PlatinumTM instruments and kits Expect revenue to accelerate in the second half of 2023 based on robust business funnel Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced financial results for the first quarter ended March 31, 2023. Recent Highlights Revenue was $254,000 on orders of $449,000 in the first quarter of 2023. Gross margin was 48.8% in the first quarter of 2023. Appointed Jeff Keyes as Chief Financial Officer effective May 15, 2023. Strengthened c

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will b

The Company began shipments of Platinum™ instruments and expects to book revenue in Q1 2023 The Company projects an extended cash runway into 2026 March 6, 2023--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Recent Business Highlights Launched Platinum, the world's first next-generation single-molecule protein sequencing system, in December 2022 and began shipping orders early in Q1 2023. Hired Grace Johnston, Ph.D. as Chief Commercial Officer and added key sales and market development personnel to scale up commercial operat

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the fourth quarter and full year 2022 before market open on Monday, March 6, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An arch

Nov. 07, 2022 -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the third quarter ending September 30, 2022. Recent Highlights Appointed Jeff Hawkins as Chief Executive Officer and director to the Board. Announced the publication of the paper entitled "Real-time dynamic single-molecule protein sequencing on an integrated semiconductor device," in Science. Formed a subsidiary to accelerate protein engineering and directed evolution programs in collaboration with development partners at the Ecole Superieure d

Oct. 17, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced that it will report financial results for the third quarter 2022 after market close on Monday, November 7, 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to

Aug. 08, 2022 -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the second quarter ending June 30, 2022. Recent Business Highlights Successfully demonstrated the recognition of 15 out of 20 amino acids, representing a path to more than 70% coverage of the human proteome and identification of up to 90% of proteins, including post-translational modifications. Released an application note, "Detecting Arginine Post-Translational Modifications Using Quantum-Si's Next-Generation Protein Sequencing Technology," demo

Jul. 18, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next generation single molecule protein sequencing, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a

May 09, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing single molecule protein sequencing, today announced financial results for the first quarter ending March 31, 2022. Recent Business Highlights Announced the appointment of Patrick Schneider as President & Chief Operating Officer. Made progress on scale-up activities, technology transfers and contract manufacturer collaborations to build operational scale in preparation for launch. Successfully completed the technology transfer to our Garnet Valley, Pennsylvania facility for the scale up of semiconductor chip production. Shared an application note demonst

Apr. 18, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing single molecule protein sequencing, today announced that it will report financial results for the first quarter 2022 after market close on Monday, May 9, 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET. Individuals interested in the listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can participate in the call by dialing (833) 927-1758 for

Feb. 28, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing single molecule protein sequencing, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Recent Business Highlights Announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of the Board, as Interim Chief Executive Officer. Formed a new Scientific Advisory Board whose goal will be to identify high-impact, routine applications for single molecule protein sequencing across research, clinical, and diagnostics. Established list prices for our protein sequencing platform in anticipation of

Founder and Executive Chairman of the Board to Advance Quantum-Si's Protein Sequencing Technology and Commercialization Strategy Feb. 14, 2022--Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si's Board of Directors, as Interim CEO. Dr. Rothberg succeeds John Stark, effective February 8, 2022, while the Company's Board of Directors commences a search process to identify a long-term CEO. "Quantum-Si's first-of-its-kind next generation protein sequencing has the potential to impact immunol

Feb. 07, 2022 -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that it will report fourth quarter and full year 2021 financial results after market close on Monday, February 28, 2022. Company management will host a conference call on the same day at 4:30 p.m. ET to discuss financial results and provide a business update. Individuals interested in listening to the conference call may do so by dialing (844) 200-6205 for domestic callers or (929) 526-1599 for international callers, followed by Conference ID: 662305. A live and archived webcast of the event will

Quantum-Si Continues Momentum and Accelerates Commercialization Efforts Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a life sciences tools company commercializing a unique protein sequencing platform, today announced financial results for the quarter ended September 30, 2021 and provided a business update. Recent Highlights Expanded Early Access program to ten, with five additional sites, and participation from leading academic centers and key industry partners Accelerated efforts to create an application ecosystem around our platform through external partnerships, including the Ecole Superieure de Physique et de Chimie Industrielles (ESPCI) in Paris and Prote

Quantum-Si Incorporated (NASDAQ:QSI), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report third quarter 2021 financial results on November 11, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on November 11, 2021, to discuss third quarter 2021 financial results and provide a business update. The conference call will be broadcast live via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. The conference call will start in listen-only mode and then open up to questions from analysts. Indivi

Quantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced financial results for the quarter ended June 30, 2021 and provided a business update. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Quantum-Si's Chief Financial Officer, will host a call today at 4:30 pm EDT to review the Company's results. Recent Highlights: Completed the business combination with HighCape Capital Acquisition Corp. ("HighCape"), adding over $511 million in cash to the balance sheet. Successfull

Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET on August 16, 2021, to discuss second quarter 2021 financial results and provide a business update. The conference call will be broadcast live in listen-only mode via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. Individuals interested in listening to the conference call on y

Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report second quarter 2021 financial results on August 12, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on August 12, 2021, to discuss second quarter 2021 financial results and provide a business update. The conference call will be broadcast live in listen-only mode via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. Individuals interested in listening to the conference call on your telephone may do so by dialing